SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PLUR

Pluri Inc. (NASDAQ:PLUR)

IL · Delayed Price · Currency is USD
Also listed: PLUR.TAHealthcare · Biotechnology
$0.94-$0.03 (-3.07%)
 
Market cap
$13.5M
Insider Score
Health Score
Listed since
Jun 30, 2003
Market Cap$13.51M-74.0%
Revenue (ttm)$2.14M+61.4%
Net Income-$48.47M-115.0%
EPS-$4.55-38.7%
Shares Out14.38M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25,866
Open$0.98
Previous Close$0.97
Day's Range$0.90 - $1.06
52-Week Range$0.85 - $3.94
Beta0.64
Analystsn/a
Price Target$12.00(+1176.60%)
Earnings DateMar 3, 2027
-2.04% (1D)
No price history available.

About PLUR

Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in advanced clinical development, with ongoing Phase III trials for muscle recovery after hip fracture surgery, Phase II studies for acute respiratory distress syndrome associated with COVID-19, and Phase I/II trials for steroid-refractory Graft-versus-Host Disease. Additionally, Pluri is advancing PLX-R18, a treatment designed to aid in incomplete hematopoietic recovery following hematopoietic cell transplantation and to address acute radiation syndrome. The company rebranded to Pluri Inc. in July 2022, having previously operated as Pluristem Therapeutics Inc.

Address
MATAM Advanced Technology Park, Haifa, HA, 3508409, IL
Market Cap
14 million
Employees
92
Industrial Classification
Biotechnology

Pluri Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
6th Percentile Overall Score
PLUR InsiderScore:39 / 99

Pluri Inc. scored higher than 6% of companies evaluated by InsiderBuying, and ranked 89th out of 107 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Pluri Inc. bought $1.25 million of stock across 1 purchase in the last 90 days, the largest of them $1.25 million.

Stake Increase

The average purchase added about 67% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$3.34M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Distressed
From PLUR’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-3.07%
5 Days
-10.48%
1 Month
-6.93%
6 Months
-60.34%
1 Year
-74.03%

$PLUR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PLUR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PLUR's directors and management

Net Shares Purchased by Insiders−900k−450k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PLUR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New PLUR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PLUR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PLUR

DFISDimensional - International Small Cap ETF$0.46

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PLUR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
71% of score
38.52
Analyst Ratings
No data yet
—
News & Sentiment
29% of score
72

News check: Certifications, earnings reporting, and CEO commentary on commercial expansion signal positive business momentum and operational progress.

Recent Insider Activity

Buys
2
Sells
0
Buy Value
$3.34M
Distinct Buyers
1

Insider Score Trend Over Time

-15.3 since Oct 30
0255075100Oct 30 — Insider Score 53.8Oct 31 — Insider Score 53.6Nov 1 — Insider Score 53.6Nov 2 — Insider Score 53.5Nov 3 — Insider Score 52.8Nov 4 — Insider Score 52.5Nov 5 — Insider Score 51.3Nov 6 — Insider Score 50.5Nov 7 — Insider Score 49.9Nov 8 — Insider Score 50.5Nov 9 — Insider Score 50.6Nov 10 — Insider Score 49.1Nov 11 — Insider Score 48.4Nov 12 — Insider Score 47.9Nov 13 — Insider Score 46.5Nov 14 — Insider Score 45.4Nov 15 — Insider Score 45.9Nov 16 — Insider Score 45.2Nov 17 — Insider Score 42.5Nov 18 — Insider Score 41.1Nov 19 — Insider Score 39.8Nov 20 — Insider Score 38.8Nov 21 — Insider Score 38.0Nov 22 — Insider Score 38.5Oct 30Nov 10Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.